{"id":31971,"date":"2020-07-04T12:15:07","date_gmt":"2020-07-04T11:15:07","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=31971"},"modified":"2021-11-19T23:51:20","modified_gmt":"2021-11-19T23:51:20","slug":"gut-brain-axis-speakers","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/","title":{"rendered":"Gut-Brain Axis 2021 Speakers"},"content":{"rendered":"
\n

\n\tOur
Speakers (A-Z)\n\t<\/h2>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tAlessio Mylonas\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Research Scientist at AC Immune<\/h5>\n

\n\t\t\t\n\tLeveraging the microbiome in Alzheimer’s disease progression and neuroinflammation\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Alessio Mylonas is an immunologist and longtime microbiome aficionado. Formerly a researcher at the Swiss Federal Institute of Technology, and University Hospital of Lausanne, he is now a senior researcher at AC Immune SA, an innovating clinical-stage biopharmaceutical research company with expertise in precision medicine for neurodegenerative diseases. He is now pursuing new targets, based on his research, in a pharmaceutical context.<\/p>\n\t\t\t\t\t\t\t\"\"\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tJane A. Foster\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Associate Professor at McMaster University<\/h5>\n

\n\t\t\t\n\tHarnessing the Potential of Microbiota-related Therapies for Brain Health\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Jane Foster is an Associate Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University in Hamilton, ON and a Scientist at St. Michael’s Hospital in Toronto, ON. Dr. Foster is an active researcher in two large translational networks – the Province of Ontario Neurodevelopmental Disorders Network (POND) and the Canadian Biomarkers in Depression (CAN-BIND).<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tJavier Ochoa-Repa\u0301raz\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Associate Professor at Eastern Washington University<\/h5>\n

\n\t\t\t\n\tThe gut microbiome as a therapeutic venue for inflammatory diseases of the central nervous system (CNS)\n\t\t\t<\/a>\n\t<\/h3>\n\t

Javier Ochoa-Repa\u0301raz research is focused on host-microbial gut interactions and the mechanisms of immunomodulation associated with protection against CNS inflammatory demyelination, with a particular focus on the impact of gut microbes regulating diseases.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tMarcus B\u00f6hme\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
R&D Specialist at Nestl\u00e9 Research<\/h5>\n

\n\t\t\t\n\tDiet & the Gut-Brain Axis: from concept to product\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Marcus B\u00f6hme is as R&D Specialist working at the Nestl\u00e9 Research Centre in Lausanne, Switzerland focusing on the Gut-Brain Axis. Prior to joining Nestl\u00e9, he completed his undergraduate training in Nutritional Science at the Friedrich-Schiller-University of Jena, Germany, where he also received his PhD in neuroscience. Subsequently, Dr. B\u00f6hme undertook a 4-year postdoctoral fellowship in the lab of Prof. John Cryan at the University College Cork, Ireland, where he studied the relationship between diet, stress and cognition with a focus on the gut microbiota as a key mediator.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartha Carlin\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Chief Executive Officer at The BioCollective<\/h5>\n

\n\t\t\t\n\tMolecular Mimicry of microbial and dietary immune triggers as the key to disease complexity in Parkinson’s\n\t\t\t<\/a>\n\t<\/h3>\n\t

Martha Carlin is an award-winning systems thinker who is changing how we understand the link between the environment, our food and water systems, and illness. Martha’s vision of the BioCollective has built a platform to accelerate the development of solutions to solve these complex problems.. Martha has the unique ability to connect seemingly unrelated things to solve problems in new ways.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tNadejda Lupolova\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Health Coach<\/h5>\n

\n\t\t\t\n\tCan a diet tackle stress?\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr Nadejda Lupolova holds a MSc in Biotechnology from the University of York and a PhD in Infection and Immunity from the University of Edinburgh, UK. \u00a0 During her time in academia she used Bioinformatics and applied Machine Learning techniques to predict bacterial \u00a0and viral phenotypes from whole genome sequenced data. Examples of her work include Pathogenicity and severity of disease prediction caused by \u00a0S. enterica and E. coli; Microbiome dynamics \u00a0following antibiotic intervention; Development of a rapid phage discovery and prediction of phage-bacteria interaction for phage therapy applications.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tNina Vinot\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
International Sales Director at TargEDys<\/h5>\n

\n\t\t\t\n\tPioneering precision probiotics: from molecular mimetism to product commercialization\n\t\t\t<\/a>\n\t<\/h3>\n\t

Before entering industry, Nina was involved in human nutrition research at Penn State University, USA, the French National Center for Scientific Research (CNRS) and the National Institute for Agronomic Research (now INRAe). She has an engineer degree from AgroParisTech, Paris Institute of Technology for Life, Food and Environmental Sciences.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tSatya Prakash\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgury in the Faculty of Medicine at McGill University<\/h5>\n

\n\t\t\t\n\tNovel Microbiome Approach For Management of Alzheimer Diseases\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Prakash research team has contributed to the advancement and development of several biomedical technologies. Superficially, his research program is focus on understanding the human microbiome, developing probiotic formulations for use in neurological disorders such as Alzheimer’s, Parkinson’s, aging, metabolic syndrome, obesity, cardiovascular diseases and in developing formulations for targeted delivery of drugs, live cells, and therapeutic molecules and medical devices such as novel stents.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tSergue\u00ef O. Fetissov\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of physiology at Rouen University and co-founder of TargEDys.<\/h5>\n

\n\t\t\t\n\tMicrobiome Mediated Appetite Regulation – First Experiences with EnteroSatys\n\t\t\t<\/a>\n\t<\/h3>\n\t

Serguei Fetissov MD, PhD, was graduated from Military Medical Academy in St Petersburg and received his PhD from Institute of Developmental Biology of Russian Academy of Science in Moscow combined with training in Pierre & Marie Curie University in Paris. He worked as a researcher and principle investigator for more than 20 years in the field of physiology, neuroscience and nutrition in academic institutions including College de France in Paris, Upstate Medical University in Syracuse, USA and Karolinska Institutet in Stockholm, Sweden.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tShahram Lavasani\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Founder and CEO at ImmuneBiotech AB<\/h5>\n

\n\t\t\t\n\tImmuneBiotics for management of neurological conditions – new clinical evidence\n\t\t\t<\/a>\n\t<\/h3>\n\t

Shahram Lavasani holds a Ph.D. degree from Lund University in Medical Inflammation Research where he studied the immunoregulation and novel immunotherapies in multiple sclerosis (MS). He is a skillful immunologist, with many years of teaching and research expertise on gastrointestinal complications in autoimmune and chronic inflammatory diseases.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tWouter de Jonge\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Professor of Neurogastroenterology at AMC, CoFounder of Gut Research<\/h5>\n

\n\t\t\t\n\tThe gut-brain and brain-gut axes in human disease\n\t\t\t<\/a>\n\t<\/h3>\n\t

Professor Wouter de Jonge received his doctoral training at University of Utrecht, and Columbia University, and received his Phd in 2001 (Medicine, University of Amsterdam and Maastricht). He took up postdoctoral positions at the AMC in Amsterdam (prof Guy Boeckxstaens) and Oxford University (prof Siamon Gordon). He chairs the gastro-intestinal research group (www.gut-research.com) at the AMC since 2013 and holds a part time W2 professorship at the Dept of Surgery at the University of Bonn, Germany.<\/p>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t<\/a>\n\t\t

\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\tDr. Yoghatama Cindya Zanzer\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t
Manager Nutrition Science at BENEO, Germany<\/h5>\n

\n\t\t\t\n\tMechanisms and current evidence of prebiotics in gut-brain-axis\n\t\t\t<\/a>\n\t<\/h3>\n\t

Dr. Yoghatama Cindya Zanzer is Manager Nutrition Science in BENEO, Germany. He received Ph.D. in Applied Human Clinical and Molecular Nutrition from Lund University, Sweden. For the last 8+ years, he has been leading cross-functional strategic projects from the interface between industry and academia in the field of prebiotics, functional carbohydrate and bioactive compounds on gut\/digestive\/gastrointestinal health, gut-brain-axis, appetite regulation, weight management, glycemic regulation as well as nutrigenomics in human clinical interventions.<\/p>\n\n<\/div>","protected":false},"excerpt":{"rendered":"

Our Speakers (A-Z) Alessio Mylonas Research Scientist at AC Immune Leveraging the microbiome in Alzheimer’s disease progression and neuroinflammation Dr. Alessio Mylonas is an immunologist and longtime microbiome aficionado. Formerly a researcher at the Swiss Federal Institute of Technology, and University Hospital of Lausanne, he is now a senior researcher at AC Immune SA, an…<\/p>\n","protected":false},"author":1,"featured_media":30835,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-31971","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nGut-Brain Axis 2021 Speakers • BioTech Pharma Summit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gut-Brain Axis 2021 Speakers • BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Our Speakers (A-Z) Alessio Mylonas Research Scientist at AC Immune Leveraging the microbiome in Alzheimer’s disease progression and neuroinflammation Dr. Alessio Mylonas is an immunologist and longtime microbiome aficionado. Formerly a researcher at the Swiss Federal Institute of Technology, and University Hospital of Lausanne, he is now a senior researcher at AC Immune SA, an...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-19T23:51:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/\",\"name\":\"Gut-Brain Axis 2021 Speakers • BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"datePublished\":\"2020-07-04T11:15:07+00:00\",\"dateModified\":\"2021-11-19T23:51:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"width\":1300,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gut-Brain Axis 2021 Speakers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow's healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gut-Brain Axis 2021 Speakers • BioTech Pharma Summit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/","og_locale":"en_US","og_type":"article","og_title":"Gut-Brain Axis 2021 Speakers • BioTech Pharma Summit","og_description":"Our Speakers (A-Z) Alessio Mylonas Research Scientist at AC Immune Leveraging the microbiome in Alzheimer’s disease progression and neuroinflammation Dr. Alessio Mylonas is an immunologist and longtime microbiome aficionado. Formerly a researcher at the Swiss Federal Institute of Technology, and University Hospital of Lausanne, he is now a senior researcher at AC Immune SA, an...","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-19T23:51:20+00:00","og_image":[{"width":1300,"height":600,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/","name":"Gut-Brain Axis 2021 Speakers • BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","datePublished":"2020-07-04T11:15:07+00:00","dateModified":"2021-11-19T23:51:20+00:00","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","width":1300,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-speakers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Gut-Brain Axis 2021 Speakers"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow's healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/31971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=31971"}],"version-history":[{"count":23,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/31971\/revisions"}],"predecessor-version":[{"id":37106,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/31971\/revisions\/37106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/30835"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=31971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}